PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.

PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.

Blog Article

Islet transplantation may potentially cure type 1 diabetes mellitus (T1DM).However, immune rejection, especially that induced by the alloreactive T-cell response, remains a restraining factor for the long-term survival of grafted islets.Programmed death ligand-1 (PD-L1) is a negative costimulatory molecule.

PD-L1 deficiency within the donor heart accelerates allograft rejection.Here, we investigate whether PD-L1 deficiency in donor islets reduces allograft survival time.Glucose Stimulation Trailer Hitch Assays were performed to evaluate whether PD-L1 deficiency has detrimental effects on islet function.

Islets isolated from PDL1-deficient mice or wild- type (WT) mice (C57BL/6j) were implanted beneath the renal capsule of streptozotocin (STZ)-induced diabetic BALB/c mice.Blood glucose levels and graft survival time after transplantation were monitored.Moreover, we analyzed the residual islets, infiltrating immune cells and alloreactive cells from the recipients.

PD-L1 deficiency within islets does not affect islet function.However, islet PD-L1 deficiency increased allograft rejection and was associated with enhanced inflammatory cell infiltration and recipient T-cell coffee table alloreactivity.This is the first report to demonstrate that PD-L1 deficiency accelerated islet allograft rejection and regulated recipient alloimmune responses.